BRIEF-Kyowa Kirin Says Presented Impact Of Baseline Dyskinesia On Safety And Efficacy Of Nourianz In Patients With Parkinson’s Disease

BRIEF-Kyowa Kirin Says Presented Impact Of Baseline Dyskinesia On Safety And Efficacy Of Nourianz In Patients With Parkinson’s Disease
IMPACT OF BASELINE DYSKINESIA ON SAFETY AND EFFICACY OF NOURIANZ IN PATIENTS WITH PARKINSON’S DISEASE PRESENTED * KYOWA KIRIN - PATIENTS HAD REDUCTIONS IN “OFF” TIME AND INCREASES IN “ON” TIME WITHOUT ... read more
Source: Bing NewsPublished on 2020-05-26